Revolution Medicines, Inc. is 11.3x more valuable than Adaptive Biotechnologies Corp by market capitalization ($30.74 B vs $2.73 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ADPT | RVMD |
|---|---|---|
| Market cap | $2.73 B | $30.74 B |
| US-listed rank | #1887 | #453 |
| Revenue (latest FY) | $276.98M | $0.00 |
| Net income (latest FY) | -$59.50M | -$1.13B |
| Net margin | -21.5% | - |
| SEC filings | 764 | 782 |
Revolution Medicines, Inc. is 11.3x more valuable than Adaptive Biotechnologies Corp by market capitalization ($30.74 B vs $2.73 B).
In their latest fiscal years, Adaptive Biotechnologies Corp reported $276.98M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Adaptive Biotechnologies Corp and Revolution Medicines, Inc., or browse the full rankings.